GEN-MKT-18-7897-A
Aug 30, 2021 | Blogs | 0 comments
5th August 2021
Read time: 2 minutes
Thailand has become the first southeast Asian country to legalize cannabis for medical use. Cannabis was originally introduced into Thailand from India, and until it was outlawed in the 1930s, it was historically used as a kitchen condiment, medicine and source of fiber.
The law legalizing medical marijuana essentially excludes all foreign companies, as well as foreign majority companies incorporated in Thailand, from producing, selling, importing, exporting and processing cannabis as well as other exclusions. This move has been viewed as an effort to protect local companies from an onslaught of highly capitalized foreign entities. The Narcotics Act of 2019 is a modification of the Narcotics Act of 1979. While the recreational use of the substance remains illegal, Thai citizens can now apply for cannabis treatment for 1 or more of 38 registered medical conditions.
The Thailand cannabis bloom
Hemp is known for its strong fiber, which can be made into rope, paper, clothing and other products, and parts of the hemp plant can be processed to make medicine, food and cosmetics. Thai households can now grow up to six pots of cannabis, helping to supply crop to public hospitals and state facilities, or use them to make food and cosmetics to supplement income.
Although hemp and cannabis are in the same family, Thai regulatory authorities differentiate between them because hemp is nearly THC-free (must be under at least 0.2% by weight).7 This difference in potency will be the focus of medical cannabis testing regulations, which are still in the works, to distinguish hemp from marijuana, given that they are essentially the same plant chemically.
Thailand is a budding cannabis market that includes both hemp and marijuana. The market value of cannabis in Thailand is estimated to be between US$660 million and US$2.5 billion by 2024.4 All eyes are on the global legalization of marijuana, and with the varied regulations in the US compared to the uniform federal regulations in Canada, it will be interesting to see if Thailand follows either of these approaches in terms of recreational use and testing standards.
DISCLAIMER: THIS IS NOT INTENDED TO PROVIDE LEGAL ADVICE
References
1. New Announcement Of Cannabis Legalization In Thailand-February 8 2021 Herrera & Partners
2. CANNABIS CATALYSTS- https://www.cannabiscatalysts.com/medical-cannabis-legalization-in-thailand
3. Cannabis for Thailand – https://cannabisforthailand.com/thailand-medical-cannabis/
4. EASTASIAFORUM – https://www.eastasiaforum.org/2021/05/13/can-medical-cannabis-in-thailand-balance-profits-and-patients/ 5. Healthline – https://www.healthline.com/health/hemp-vs-marijuana#marijuana 6. Bloomberg – https://www.bloomberg.com/news/articles/2021-03-05/thai-families-can-grow-six-pots-of-cannabis-each-as-rules-eased 7. HempToday – https://hemptoday.net/thailand-sets-strict-rules-for-cosmetics-hemp-under-3-year-govt-monopoly/
RUO-MKT-18-13469
It is no secret that (bio)pharmaceutical research and development is complex, both scientific and regulatory processes. Here is an overview of just some of the ways SCIEX is working to support these challenges.
In a recent webinar, available on demand, scientists Luiza Chrojan and Ryan Hylands from Pharmaron, provided insights into the deployment of capillary gel electrophoresis (CGE) within cell and gene therapy. Luiza and Ryan shared purity data on plasmids used for adeno-associated virus (AAV) manufacturing and data on AAV genome integrity, viral protein (VP) purity and VP ratios using the BioPhase 8800 system.
Last year, Technology Networks hosted two webinars that featured groundbreaking research utilizing SWATH DIA (data-independent acquisition) for exposomics and metabolomics. Researchers Dr. Vinicius Verri Hernandes from the University of Vienna and Dr. Cristina Balcells from Imperial College London (ICL) demonstrated how a DIA approach can be successfully implemented in small molecule analysis using the ZenoTOF 7600 system. Their innovative approaches highlight the potential of SWATH DIA to enhance the detection and analysis of chemical exposures and metabolites, paving the way for new insights into environmental health and disease mechanisms.
Posted by
You must be logged in to post a comment.
Share this post with your network